The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
Chengyuan Liang(Shaanxi University of Science and Technology), Suresh Thareja(Guru Ghasidas Vishwavidyalaya), Xiaodong Ren(Guizhou Provincial People's Hospital), Danni Tian(Shaanxi University of Science and Technology), Minyi Jia(Shaanxi University of Science and Technology), Shunjun Ding(Shaanxi University of Science and Technology), Minhang Xin(Xi'an Jiaotong University)
Cited by 168
Related Papers
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
|Pharmaceuticals|2023|317
Small molecule selenium-containing compounds: Recent development and therapeutic applications
|European Journal of Medicinal Chemistry|2021|233
Review of the molecular mechanisms of Ganoderma lucidum triterpenoids: Ganoderic acids A, C2, D, F, DM, X and Y
|European Journal of Medicinal Chemistry|2019|192
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
|Pharmaceuticals|2022|190
Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
|European Journal of Medicinal Chemistry|2020|120